Related references
Note: Only part of the references are listed.EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations
Isabelle Beuchat et al.
NEURO-ONCOLOGY (2022)
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G. Holtzman et al.
NEURO-ONCOLOGY (2021)
Pre-Infusion Neurofilament Light Chain (NfL) Levels Predict the Development of Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) - a Multicenter Retrospective Study
Omar H. Butt et al.
BLOOD (2021)
Safety and Efficacy of Two Anakinra Dose Regimens for Refractory CRS or Icans after CAR T-Cell Therapy
Nicolas Gazeau et al.
BLOOD (2021)
A Phase II Trial of Anakinra for the Prevention of CART Cell Mediated Neurotoxicity
Matthew J. Frigault et al.
BLOOD (2021)
Easix Predicts Severe Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neuro-Toxicity Syndrome (ICANS) in Patients Receiving CD19Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy
Felix Korell et al.
BLOOD (2021)
Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center study
Carlen Yuen et al.
IMMUNOTHERAPY (2021)
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
Brandon Douglas Brown et al.
FRONTIERS IN ONCOLOGY (2021)
Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study
Didier Maillet et al.
NEURO-ONCOLOGY (2021)
Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel
Kitsada Wudhikarn et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Incidence, mitigation, and management of neurologic adverse events in patients with multiple myeloma (MM) treated with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-2.
Hermann Einsele et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
CD19 CAR T-cell product type independently impacts CRS and ICANS severity in patients with aggressive NHL.
Jordan Gauthier et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum et al.
BLOOD ADVANCES (2021)
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
Ana Cordeiro et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy
Julia Ruark et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
Sean McGrath et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
Daniel B. Rubin et al.
JAMA NEUROLOGY (2020)
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
Kitsada Wudhikarn et al.
BLOOD ADVANCES (2020)
Neurological adverse events following CAR T-cell therapy: a real-world analysis
Ajeet Gajra et al.
IMMUNOTHERAPY (2020)
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma
Paolo Strati et al.
BLOOD ADVANCES (2020)
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
Catherine Belin et al.
SCIENTIFIC REPORTS (2020)
Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial
Richard T. Maziarz et al.
BLOOD ADVANCES (2020)
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
Philipp Karschnia et al.
BLOOD (2019)
Neurological toxicities associated with chimeric antigen receptor T-cell therapy
Daniel B. Rubin et al.
BRAIN (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell Therapy
Jorge Garcia Borrega et al.
HEMASPHERE (2019)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
Bianca D. Santomasso et al.
CANCER DISCOVERY (2018)
Neurotoxicity after CTL019 in a pediatric and young adult cohort
Jacqueline S. Gofshteyn et al.
ANNALS OF NEUROLOGY (2018)
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy
Haneen Shalabi et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema
Matthew Torre et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Juliane Gust et al.
CANCER DISCOVERY (2017)
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy
Fang Chen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Share Paper
